Thus, targeting GPR10 and NPFFR2 receptors may be beneficial not only for obesity treatment but also for attenuating anxiety since the deficiency of both receptors resulted in anxiety-like behavior in dKO females. This evidence concerns the gene PRLHR and obesity due to melanocortin 4 receptor deficiency.